Zobrazeno 1 - 10
of 77
pro vyhledávání: ''
Autor:
Melissa J. Lefebvre, Marisa Battistella, Patrick Ng, Bassem Hamandi, Shahid Husain, Joseph Lee
Publikováno v:
Annals of Pharmacotherapy. 55:509-529
Objectives To examine current knowledge on the clinical utility of therapeutic drug monitoring (TDM) in voriconazole therapy, the impact of CYP2C19 genotype on voriconazole plasma concentrations, and the role of CYP2C19 genotyping in voriconazole the
Autor:
Kelly Slipak, Jordan R. Covvey, David E. Zimmerman, David Fiumara, Zachary Moszczenski, Kelly Mazzei, Olivia Erickson, Anthony J. Guarascio, Branden D. Nemecek
Publikováno v:
Annals of Pharmacotherapy. 54:644-651
Background: A vancomycin target of area under the curve to minimum inhibitory concentration (AUC:MIC) ratio ≥400 is recommended for treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Objective: To evaluate vancomycin total
Publikováno v:
Annals of Pharmacotherapy. 54:151-156
Background: High-intensity atorvastatin dosing may lead to a greater incidence of adverse events, subsequently leading to discontinuation and suboptimal risk reduction for major adverse cardiovascular events. No previous studies exist investigating t
Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis
Autor:
Amanda M. Stahnke, Kathryn M Holt
Publikováno v:
Annals of Pharmacotherapy. 52:473-483
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of ocrelizumab, a new B-cell–targeted therapy for multiple sclerosis (MS). Data Sources: A comprehensive search of PubMed and OVID/MEDLINE was conducted using search term
Publikováno v:
Annals of Pharmacotherapy. 51:768-773
Background: Despite large interpatient variability in dose response, heparin is utilized for treatment of venous thromboembolism (VTE). Current data on the optimal heparin dosing in obese patients are conflicting. Objective: The objective was to eval
Autor:
Sarah E. Petite
Publikováno v:
Annals of Pharmacotherapy. 51:696-705
Objective: To compare the available literature regarding the use of long-acting muscarinic antagonist (LAMA)/long-acting β2 agonists (LABA) and inhaled corticosteroid (ICS)/LABA combination inhaler therapy in chronic obstructive pulmonary disease (C
Publikováno v:
Annals of Pharmacotherapy. 51:239-244
Background: Many infants and children receive acetaminophen and/or ibuprofen during febrile illness. Previously, some studies have linked acetaminophen and ibuprofen use to wheezing and exacerbation of asthma symptoms in infants and children. Objecti
Autor:
Nghi B. Ha, Randolph E. Regal
Publikováno v:
Annals of Pharmacotherapy. 50:402-409
Objective: To review current literature for anticoagulation in patients with cirrhosis and provide a summary of the effects of cirrhosis on the coagulation cascade, therapeutic monitoring through interpretation of antifactor Xa (anti-Xa), activated p
Autor:
Long To, Brian D. Desmet, Edward G. Szandzik, Philip Kuriakose, Jessica Schillig, James S. Kalus
Publikováno v:
Annals of Pharmacotherapy. 45:195-200
BACKGROUND: The use of anticoagulant medications is complex and prone to error in the inpatient setting. Patients with heparin-induced thrombocytopenia (HIT) must receive treatment with alternative anticoagulant agents to ensure optimal patient outco
Autor:
Alma Angélica Rodríguez-Carreón, Judith Domínguez-Cherit, Gabriela Moreno-Coutiño, Roberto Arenas, Lirio López-García, Elisa Vega-Memije
Publikováno v:
Annals of Pharmacotherapy. 42:127-130
Objective:To report a case of simultaneous erythema nodosum and erythema multiforme after local lidocaine injection.Case Summary:A 33-year-old female experienced coexisting erythema nodosum and erythema multiforme after lidocaine spray was used for u